Pediatrix Medical Group (MD) Q1 Earnings and Revenues Surpass Estimates

Core Insights - Pediatrix Medical Group reported quarterly earnings of $0.33 per share, exceeding the Zacks Consensus Estimate of $0.25 per share, and showing an increase from $0.20 per share a year ago, representing a 32% earnings surprise [1] - The company achieved revenues of $458.36 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.86%, although this is a decrease from $495.1 million in the same quarter last year [2] - The stock has lost approximately 1.3% since the beginning of the year, while the S&P 500 has declined by 3.9% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.42 on revenues of $466.24 million, and for the current fiscal year, it is $1.55 on revenues of $1.88 billion [7] - The estimate revisions trend for Pediatrix Medical Group is favorable, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Medical Services industry, to which Pediatrix Medical Group belongs, is currently ranked in the top 25% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8]